These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 7908224

  • 1. Murine heparin cofactor II: purification, cDNA sequence, expression, and gene structure.
    Zhang GS, Mehringer JH, Van Deerlin VM, Kozak CA, Tollefsen DM.
    Biochemistry; 1994 Mar 29; 33(12):3632-42. PubMed ID: 7908224
    [Abstract] [Full Text] [Related]

  • 2. Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli.
    Blinder MA, Marasa JC, Reynolds CH, Deaven LL, Tollefsen DM.
    Biochemistry; 1988 Jan 26; 27(2):752-9. PubMed ID: 2894851
    [Abstract] [Full Text] [Related]

  • 3. Isolation of frog and chicken cDNAs encoding heparin cofactor II.
    Colwell NS, Tollefsen DM.
    Thromb Haemost; 1998 Nov 26; 80(5):784-90. PubMed ID: 9843172
    [Abstract] [Full Text] [Related]

  • 4. Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11.
    Herzog R, Lutz S, Blin N, Marasa JC, Blinder MA, Tollefsen DM.
    Biochemistry; 1991 Feb 05; 30(5):1350-7. PubMed ID: 1671335
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rapid changes in the exon/intron structure of a mammalian thrombin inhibitor gene.
    Kamp PB, Ragg H.
    Gene; 1999 Mar 18; 229(1-2):137-44. PubMed ID: 10095113
    [Abstract] [Full Text] [Related]

  • 7. Identification and characterization of a novel isoform of heparin cofactor II in human liver.
    Bano S, Fatima S, Ahamad S, Ansari S, Gupta D, Tabish M, Rehman SU, Jairajpuri MA.
    IUBMB Life; 2020 Oct 18; 72(10):2180-2193. PubMed ID: 32827448
    [Abstract] [Full Text] [Related]

  • 8. Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji).
    Kondo S, Tokunaga F, Kario K, Matsuo T, Koide T.
    Blood; 1996 Feb 01; 87(3):1006-12. PubMed ID: 8562924
    [Abstract] [Full Text] [Related]

  • 9. Deletion mutagenesis of heparin cofactor II: defining the minimum size of a thrombin inhibiting serpin.
    Sheffield WP, Blajchman MA.
    FEBS Lett; 1995 May 29; 365(2-3):189-92. PubMed ID: 7781777
    [Abstract] [Full Text] [Related]

  • 10. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
    Tollefsen DM.
    Adv Exp Med Biol; 1992 May 29; 313():167-76. PubMed ID: 1442260
    [Abstract] [Full Text] [Related]

  • 11. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
    Blinder MA, Tollefsen DM.
    J Biol Chem; 1990 Jan 05; 265(1):286-91. PubMed ID: 2104620
    [Abstract] [Full Text] [Related]

  • 12. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
    Van Deerlin VM, Tollefsen DM.
    J Biol Chem; 1991 Oct 25; 266(30):20223-31. PubMed ID: 1939083
    [Abstract] [Full Text] [Related]

  • 13. Sorbitol dehydrogenase. Full-length cDNA sequencing reveals a mRNA coding for a protein containing an additional 42 amino acids at the N-terminal end.
    Wen Y, Bekhor I.
    Eur J Biochem; 1993 Oct 01; 217(1):83-7. PubMed ID: 8223590
    [Abstract] [Full Text] [Related]

  • 14. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
    Derechin VM, Blinder MA, Tollefsen DM.
    J Biol Chem; 1990 Apr 05; 265(10):5623-8. PubMed ID: 2138609
    [Abstract] [Full Text] [Related]

  • 15. The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.
    Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP.
    BMC Biochem; 2013 Mar 07; 14():6. PubMed ID: 23496873
    [Abstract] [Full Text] [Related]

  • 16. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL, Ji L, Li YD.
    Yi Chuan Xue Bao; 2004 May 07; 31(5):431-43. PubMed ID: 15478601
    [Abstract] [Full Text] [Related]

  • 17. The interaction of glycosaminoglycans with heparin cofactor II.
    Tollefsen DM.
    Ann N Y Acad Sci; 1994 Apr 18; 714():21-31. PubMed ID: 8017769
    [Abstract] [Full Text] [Related]

  • 18. Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase.
    Li CM, Hong SB, Kopal G, He X, Linke T, Hou WS, Koch J, Gatt S, Sandhoff K, Schuchman EH.
    Genomics; 1998 Jun 01; 50(2):267-74. PubMed ID: 9653654
    [Abstract] [Full Text] [Related]

  • 19. Genetic variants and evolutionary analyses of heparin cofactor II.
    Kumar A, Bhandari A, Sarde SJ, Goswami C.
    Immunobiology; 2014 Sep 01; 219(9):713-28. PubMed ID: 24950623
    [Abstract] [Full Text] [Related]

  • 20. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
    Liaw PC, Austin RC, Fredenburgh JC, Stafford AR, Weitz JI.
    J Biol Chem; 1999 Sep 24; 274(39):27597-604. PubMed ID: 10488098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.